In 2024, SIA "SILVANOLS" had revenue of 5.3 million EUR and profit of 178.2 thousand EUR. The company has 53 employees. Beneficial owners: Andrejs Leibovičs, Jeļena Ņikitina, Roberts Tavjevs and 1 more.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 5,3m € -5.0% | 5,6m € +8.9% | 5,1m € +57.5% |
Profit | 178,2k € -50.9% | 363,3k € +18.6% | 306,3k € +74.8% |
Assets | 3,5m € +3.8% | 3,4m € +17.1% | 2,9m € +0.9% |
Liabilities | 1,3m € -3.6% | 1,4m € +10.9% | 1,2m € -18.5% |
Equity | 2,2m € +8.8% | 2m € +21.7% | 1,7m € +22.4% |
Employees | 52 +2.0% | 51 -5.6% | 54 +1.9% |
Overall rating | A+92/100 |
Financial health | 95/100 |
Credit history | 100/100 |
Legal history | 100/100 |
Business activity | 60/100 |
| Overall risk | Low |
No risk flags | |
No tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| Board chairman | Independently | ||||
| Board member | Together with at least | ||||
| Board member | Together with at least |
| Name | Changed |
|---|---|
| Sabiedrība ar ierobežotu atbildību "SILVANOLS" | 8 April 2004 |
| Sabiedrība ar ierobežotu atbildību "Silvanols" | 22 March 2005 |
| Sabiedrība ar ierobežotu atbildību "SILVANOLS" | 8 April 2004 |
| Sabiedrība ar ierobežotu atbildību "Silvanols" | 22 March 2005 |
| Sabiedrība ar ierobežotu atbildību "SILVANOLS" | 8 April 2004 |
| Sabiedrība ar ierobežotu atbildību "Silvanols" | 22 March 2005 |
| Sabiedrība ar ierobežotu atbildību "SILVANOLS" | 8 April 2004 |
| Sabiedrība ar ierobežotu atbildību "Silvanols" | 22 March 2005 |
| Sabiedrība ar ierobežotu atbildību "SILVANOLS" | 8 April 2004 |
| Sabiedrība ar ierobežotu atbildību "Silvanols" | 22 March 2005 |
| Sabiedrība ar ierobežotu atbildību "SILVANOLS" | 8 April 2004 |
| Sabiedrība ar ierobežotu atbildību "Silvanols" | 22 March 2005 |
| Sabiedrība ar ierobežotu atbildību "SILVANOLS" | 8 April 2004 |
| Sabiedrība ar ierobežotu atbildību "Silvanols" | 22 March 2005 |
| Sabiedrība ar ierobežotu atbildību "SILVANOLS" | 8 April 2004 |
| Sabiedrība ar ierobežotu atbildību "Silvanols" | 22 March 2005 |
| Sabiedrība ar ierobežotu atbildību "SILVANOLS" | 8 April 2004 |
| Sabiedrība ar ierobežotu atbildību "Silvanols" | 22 March 2005 |
| Sabiedrība ar ierobežotu atbildību "SILVANOLS" | 8 April 2004 |
| Sabiedrība ar ierobežotu atbildību "Silvanols" | 22 March 2005 |
Project count
46
Total funding
€68 933 003
EU support
€31 250 000
| Project | Period | Role | Funding received | Status |
|---|---|---|---|---|
FARMĀCIJAS, BIOMEDICĪNAS UN MEDICĪNAS TEHNOLOĢIJU KOMPETENCES CENTRS 5.1.1.2.i.0/1/22/A/CFLA/004 Program: AF | 2023. gada 30. janvāris until 2026. gada 30. jūnijs | partner | - | Līgums |
FARMĀCIJAS, BIOMEDICĪNAS UN MEDICĪNAS TEHNOLOĢIJU KOMPETENCES CENTRS 5.1.1.2.i.0/1/22/A/CFLA/004 Program: AF | 2023. gada 30. janvāris until 2026. gada 30. jūnijs | partner | - | Līgums |
FARMĀCIJAS, BIOMEDICĪNAS UN MEDICĪNAS TEHNOLOĢIJU KOMPETENCES CENTRS 5.1.1.2.i.0/1/22/A/CFLA/004 Program: AF | 2023. gada 30. janvāris until 2026. gada 30. jūnijs | partner | - | Līgums |
FARMĀCIJAS, BIOMEDICĪNAS UN MEDICĪNAS TEHNOLOĢIJU KOMPETENCES CENTRS 5.1.1.2.i.0/1/22/A/CFLA/004 Program: AF | 2023. gada 30. janvāris until 2026. gada 30. jūnijs | partner | - | Līgums |
FARMĀCIJAS, BIOMEDICĪNAS UN MEDICĪNAS TEHNOLOĢIJU KOMPETENCES CENTRS 5.1.1.2.i.0/1/22/A/CFLA/004 Program: AF | 2023. gada 30. janvāris until 2026. gada 30. jūnijs | partner | - | Līgums |
FARMĀCIJAS, BIOMEDICĪNAS UN MEDICĪNAS TEHNOLOĢIJU KOMPETENCES CENTRS 5.1.1.2.i.0/1/22/A/CFLA/004 Program: AF | 2023. gada 30. janvāris until 2026. gada 30. jūnijs | partner | - | Līgums |
FARMĀCIJAS, BIOMEDICĪNAS UN MEDICĪNAS TEHNOLOĢIJU KOMPETENCES CENTRS 5.1.1.2.i.0/1/22/A/CFLA/004 Program: AF | 2023. gada 30. janvāris until 2026. gada 30. jūnijs | partner | - | Līgums |
FARMĀCIJAS, BIOMEDICĪNAS UN MEDICĪNAS TEHNOLOĢIJU KOMPETENCES CENTRS 5.1.1.2.i.0/1/22/A/CFLA/004 Program: AF | 2023. gada 30. janvāris until 2026. gada 30. jūnijs | partner | - | Līgums |
FARMĀCIJAS, BIOMEDICĪNAS UN MEDICĪNAS TEHNOLOĢIJU KOMPETENCES CENTRS 5.1.1.2.i.0/1/22/A/CFLA/004 Program: AF | 2023. gada 30. janvāris until 2026. gada 30. jūnijs | partner | - | Līgums |
FARMĀCIJAS, BIOMEDICĪNAS UN MEDICĪNAS TEHNOLOĢIJU KOMPETENCES CENTRS 5.1.1.2.i.0/1/22/A/CFLA/004 Program: AF | 2023. gada 30. janvāris until 2026. gada 30. jūnijs | partner | - | Līgums |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
5.1.1.2.i.0/1/22/A/CFLA/004 | - | partner | - | - |
SIA "SILVANOLS" is located at Rīga, Kurbada iela 2A, LV-1009.
In 2024, SIA "SILVANOLS" had revenue of 5 279 088 EUR and profit of 178 226 EUR. Compared to previous year, revenue decreased by 5.0%. View full financial report →
In 2024, SIA "SILVANOLS" had an average of 53 employees. View tax history →
The beneficial owners of SIA "SILVANOLS" are Andrejs Leibovičs, Jeļena Ņikitina, Roberts Tavjevs and Sergejs Korņijenko. View ownership details →
Yes, SIA "SILVANOLS" is registered as an active VAT payer with VAT number LV40003233170.
In 2024, the average gross salary at SIA "SILVANOLS" was approximately 1719,14 € per month (net ~ 1276,33 €). This is an approximate calculation. View salary details →
SIA "SILVANOLS" was founded on December 8, 1994. The company has been operating for 32 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 32 years | 2 - 6 | 86% | |
Net revenue | 5 279 088,00 € | 1 - 5 | 89% | |
Profit | 178 226,00 € | 3 - 7 | 82% | |
Equity | 2 214 536,00 € | 2 - 6 | 82% | |
Assets | 3 528 533,00 € | 2 - 6 | 86% | |
Fixed assets | 700 883,00 € | - | 90% | |
Liquidity | 3.58 | - | 90% | |
Profitability | 3.4% | - | 10% | |
Registered capital | 703 810,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Latvian company register.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| Akciju sabiedrība "Olpha" | 703 810 | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Andrejs Leibovičs | LV | ||
| Jeļena Ņikitina | LV | ||
| Roberts Tavjevs | LV | ||
| Sergejs Korņijenko | LV |